BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 11403986)

  • 1. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
    Zackheim JA; Abercrombie ED
    Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.
    Byrnes EM; Reilly A; Bruno JP
    Synapse; 1997 Jul; 26(3):254-68. PubMed ID: 9183815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Neurosci Lett; 1994 May; 173(1-2):59-62. PubMed ID: 7936424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
    Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
    J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D1 receptors modulate striatal dopamine release induced by the stimulation of both D1 and D2 receptors: in vivo voltammetric data revisited.
    Fechtali T; Issoual D; Abraini JH
    J Physiol Paris; 1994; 88(5):331-3. PubMed ID: 7787831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences.
    Harsing LG; Zigmond MJ
    Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement.
    Wolterink G; Phillips G; Cador M; Donselaar-Wolterink I; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1993; 110(3):355-64. PubMed ID: 7831431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices.
    Arias-Montaño JA; Floran B; Garcia M; Aceves J; Young JM
    Br J Pharmacol; 2001 May; 133(1):165-71. PubMed ID: 11325806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation.
    Steinberg R; Souilhac J; Rodier D; Alonso R; Emonds-Alt X; Le Fur G; Soubrié P
    Neuroscience; 1998 May; 84(2):511-8. PubMed ID: 9539221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR; Brooderson RJ; White FJ
    Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.